1 / 55

指導老師:鄭伯智老師、林宏榮老師 學生:林怡君 (N99H0005) 報告日期 :2011/05/01

MicroRNA Silencing of Tumor Suppressor DLC-1 Promotes Efficient Hepatitis C Virus Replication in Primary Human Hepatocytes. 指導老師:鄭伯智老師、林宏榮老師 學生:林怡君 (N99H0005) 報告日期 :2011/05/01. HEPATOLOGY, 2011;53:53-61. Introduction. MicroRNA (miRNAs).

Download Presentation

指導老師:鄭伯智老師、林宏榮老師 學生:林怡君 (N99H0005) 報告日期 :2011/05/01

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MicroRNA Silencing of Tumor Suppressor DLC-1 Promotes Efficient Hepatitis C Virus Replication in Primary Human Hepatocytes 指導老師:鄭伯智老師、林宏榮老師 學生:林怡君(N99H0005) 報告日期:2011/05/01 HEPATOLOGY, 2011;53:53-61

  2. Introduction

  3. MicroRNA (miRNAs) The first miRNA, lin-4, was identified in 1993 in a genetic screen for mutants that disrupt the timing of post-embryonic development in Caenorhabditis elegans (Lee et al., 1993). miRNAs are approximately 22-nucleotide noncoding RNAs that constitute silencers of target gene expression. Development 132, 4645-4652

  4. Development, 2005

  5. Deregulated cell proliferation and apoptosis play a major role in hepatocellular carcinoma (HCC). MicroRNAs participate in the modulation of key molecules linked to hepatocarcinogenesis. Clin Cancer Res 2009;15(16):5073–81

  6. Hepatitis C Virus (HCV)

  7. Pathology of HCV • Acute Hepatitis C: • Generally benign: • No jaundice (80%) • Usually asymptomatic • Can be severe, but liver failure rare Only real threat of acute Hepatitis C is its ability to reach chronic stages undetected and untreated.

  8. Pathology of HCV • Chronic Hepatitis C: • 70% of patients become chronic • Possible results: • Cirrhosis • End-stage liver disease • Hepatocellular carcinoma

  9. The gene deleted in liver cancer-1 (DLC-1) is located on human chromosome 8p21–22, a region thought to harbor tumor suppressorgenes on the basis of its frequent deletion or loss of heterozygosity in a variety of human cancers, including hepatocellular carcinoma (HCC). Deleted in Liver Cancer-1 (DLC-1) Oncogene (2004) 23, 1308–1313

  10. HCV MiRNA HCV Chronic Hepatitis C ? DLC-1 Induce Infected cell apoptosis Cancer

  11. Materials and Methods

  12. Primary Hepatocyte Coculture HCV 1a、1b、2a infection RNA-Primed, Array-Based Klenow Enzyme Assay Flow Cytometry of Ki67 Nuclear Antigen Fluorescence Stained Reverse-Transcription, and Quantitative PCR Western Blot Analysis Luciferase Reporter Assay

  13. NATURE METHODS | VOL.1 NO.2 | NOVEMBER 2004

  14. Luciferase Reporter Assay

  15. Results

  16. Fig. 1. Changes in miRNAs in HCV-infected primary hepatocytes. Array-based Klenow extension profiles are shown for pairwise comparison of uninfected hepatocyte miRNAs with hepatocytes infected with HCV genotype 1a (A), genotype 1b (B), or genotype 2a (C).

  17. Fig. 2. Changes in miR-141 and miR-200a upon HCV infection of hepatocytes.

  18. Summary-1 cells infected with the HCV strains showed induced expression of miR-141, miR-200a, and miR-200b and miR-200c.

  19. Fig. 3. Inhibition of DLC-1 expression by miR-141 induced in HCV infected hepatocytes.

  20. Summary-2 The results suggest that DLC-1 expression in HCV1a-infected cells is regulated by intracellular miR-141.

  21. Fig. 4. DLC-1 protein level is reduced in cells with replicating HCV.

  22. Fig. 5. Changes in DLC1 protein levels in response to miR-141 in uninfected and HCV1a-infected cells.

  23. +-+ +-- ++- +-- +-+ ++- Fig. 6. (A) Effects of miR-141 on HCV RNA replication. (B) Effects of miR-141 on the release of mature HCV particles from infected cells.

  24. Fig. 6.(C) Effects of miR-141 on DLC-1 mRNA.

  25. Summary- 3 HCV replication in infected hepatocytes relies on miR-141–mediated depletion of tumor suppressor DLC-1.

  26. Uninfected control HCV 1a infection DLC-1+HCV 1a infection Fig. 7. (A) Immunostaining of Ki67 nuclear antigen with fluorescein isothiocyanate. (B) Quantitation of Ki67-positive cells.

  27. Fig. 7.(C) Quantitation of Ki67-positive cells by flow cytometry.

  28. Summary- 4 The results showed an approximately 40% increase in cell proliferation of HCV1a-infected hepatocytes. The increased cell proliferation is neutralized when the DLC-1 level was artificially increased through transfection with a DLC-1 expression vector.

  29. Discussion

  30. Efficient HCV replication is correlated with miR-141–mediated reduction of DLC-1 protein in virus infected cells. The exact mechanism by which miR-141 or DLC-1 modulate virus replication is not clear.

  31. Conclusion

  32. HCV DLC-1 MiRNA HCV Chronic Hepatitis C Induce Infected cell apoptosis Cancer

  33. Thanks for your attention!!

  34. Examples of miRNA Functions & Relevance of miRNA to Human Biology

  35. Development 132, 4645-4652

  36. Nature Biotechnology 25, 631 - 638 (2007)

  37. HCV Structure • Virion: • Enveloped • Icosahedral capsid • 40-60 nm in diameter • RNA virus • Single-stranded • Positive-sense • 9400 nucleotide

More Related